Theodore Tselios Selected Research

Immunodominant Epitopes

2/2018	Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis.
11/2013	Divergent and convergent synthesis of polymannosylated dibranched antigenic peptide of the immunodominant epitope MBP(83-99).
3/2010	NMR structural elucidation of myelin basic protein epitope 83-99 implicated in multiple sclerosis.
8/2004	NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodore Tselios Research Topics

Disease

23	Multiple Sclerosis 10/2020 - 01/2002
14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2020 - 01/2002
4	Inflammation (Inflammations) 09/2021 - 01/2002
3	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 01/2002
3	Encephalomyelitis (Myeloencephalitis) 01/2020 - 03/2005
3	Neoplasms (Cancer) 01/2020 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 03/2010 - 01/2005
1	Human Influenza (Influenza) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Necrosis 09/2011
1	Prostatic Neoplasms (Prostate Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

18	Peptides (Polypeptides)IBA 10/2020 - 01/2002
11	EpitopesIBA 10/2020 - 01/2002
7	LigandsIBA 08/2015 - 01/2002
5	AntigensIBA 01/2020 - 01/2005
5	Myelin Basic ProteinIBA 01/2018 - 01/2002
4	MannansIBA 10/2020 - 01/2009
4	Immunodominant EpitopesIBA 02/2018 - 08/2004
3	Myelin-Oligodendrocyte GlycoproteinIBA 10/2020 - 12/2009
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020 - 03/2011
3	AutoantigensIBA 01/2020 - 01/2002
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2015
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2019 - 03/2011
2	Cyclic PeptidesIBA 01/2018 - 03/2005
2	Myelin ProteinsIBA 01/2017 - 01/2005
2	Amino Acids FDA Link 01/2017 - 01/2015
2	Biological ProductsIBA 01/2016 - 01/2005
2	myelin oligodendrocyte glycoprotein (35-55)IBA 01/2016 - 11/2014
2	Phosphotransferases (Kinase)IBA 09/2011 - 12/2009
2	NF-kappa B (NF-kB)IBA 09/2011 - 12/2009
2	CytokinesIBA 12/2008 - 03/2005
2	Proteins (Proteins, Gene)FDA Link 01/2006 - 08/2004
1	Sweetening Agents (Sweeteners)IBA 09/2021
1	EnzymesIBA 09/2021
1	Lipoxygenase (Lipoxygenase-1)IBA 09/2021
1	Polysaccharides (Glycans)IBA 10/2020
1	polymannoseIBA 10/2020
1	AsparagineIBA 10/2020
1	LipidsIBA 01/2020
1	Dimyristoylphosphatidylcholine (DMPC)IBA 01/2020
1	AmidesIBA 01/2018
1	myelin basic protein 87-99IBA 01/2018
1	AnthraquinonesIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2011
1	Glucose (Dextrose)FDA LinkGeneric 09/2011
1	Leuprolide (Lupron)FDA LinkGeneric 03/2011
1	AndrogensIBA 03/2011
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 03/2010
1	myelin basic protein 83-99IBA 03/2010
1	SolutionsIBA 03/2010
1	I-kappa B KinaseIBA 12/2009
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 12/2009
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2006
1	VaccinesIBA 01/2006
1	alpha-AmylasesIBA 01/2006
1	Ion Channels (Ion Channel)IBA 01/2006
1	Interleukin-10 (Interleukin 10)IBA 03/2005
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 03/2005
1	Arginine (L-Arginine)FDA Link 08/2004

Therapy/Procedure

6	Immunotherapy 10/2020 - 10/2004